Name:
Levophenacylmorphan
Type:
Opioid
AKA:
N/A
Levophenacylmorphan image
Synthetic substance, no natural derivative
IUPAC Logo
Levophenacylmorphan image
Levophenacylmorphan, a synthetic opioid, was developed as a research compound to explore its analgesic properties. Its exact historical context is less documented, but it represents the broader efforts to create and study synthetic opioids for pain management and research into opioid receptor interactions.
Synthetic Substances Image
Levophenacylmorphan, an opioid derivative, is used for pain management. As a downer, it induces significant sedation and respiratory depression. Short-term effects include pain relief and euphoria, while long-term use can lead to addiction and tolerance. Overdose risks involve severe respiratory depression and potential fatality. Safe dosing involves careful medical supervision. Recent findings emphasize its efficacy and potential for addiction.
N/A
Levophenacylmorphan, an opioid derivative, impacts opioid receptors to provide pain relief and euphoria. Psychological effects include mood changes and cognitive impairment. Immediate effects last several hours, with long-term use carrying risks of dependence and mental health issues. Research focuses on its efficacy, safety, and potential for abuse.
N/A
Levophenacylmorphan, a synthetic opioid, is used for its analgesic properties. Its cultural significance lies in its role in opioid pharmacotherapy and the broader discussions about opioid medications. Levophenacylmorphan reflects the challenges of managing pain and the risks associated with opioid use, including dependency and misuse. Its role in the cultural narrative is one of addressing pain management while navigating the complexities of opioid medications.
N/A